SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $686,472 | +1.6% | 5,663 | -4.0% | 0.00% | 0.0% |
Q2 2023 | $675,439 | -27.1% | 5,898 | -12.3% | 0.00% | -25.0% |
Q1 2023 | $926,769 | +20.4% | 6,724 | +13.2% | 0.00% | 0.0% |
Q4 2022 | $769,835 | +83.7% | 5,941 | +56.8% | 0.00% | +100.0% |
Q3 2022 | $419,000 | +61.2% | 3,788 | +9.1% | 0.00% | 0.0% |
Q2 2022 | $260,000 | -3.0% | 3,471 | +1.3% | 0.00% | 0.0% |
Q1 2022 | $268,000 | -11.3% | 3,427 | +2.3% | 0.00% | 0.0% |
Q4 2021 | $302,000 | -45.4% | 3,350 | -44.0% | 0.00% | -60.0% |
Q3 2021 | $553,000 | +7.2% | 5,977 | -10.0% | 0.01% | 0.0% |
Q2 2021 | $516,000 | +2.6% | 6,642 | -1.5% | 0.01% | 0.0% |
Q1 2021 | $503,000 | -57.2% | 6,743 | -2.1% | 0.01% | -68.8% |
Q4 2020 | $1,174,000 | +19.3% | 6,885 | -1.0% | 0.02% | 0.0% |
Q3 2020 | $984,000 | -17.2% | 6,955 | -3.0% | 0.02% | -20.0% |
Q2 2020 | $1,188,000 | +12.9% | 7,170 | -36.6% | 0.02% | -13.0% |
Q1 2020 | $1,052,000 | -32.5% | 11,315 | -6.3% | 0.02% | -8.0% |
Q4 2019 | $1,559,000 | – | 12,080 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |